Dashboard Market News Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Akebia Therapeutics Inc banner

Akebia Therapeutics Inc
F:AX9

Watchlist Manager
Akebia Therapeutics Inc Logo
Akebia Therapeutics Inc
F:AX9
Watchlist
Price: 0.8004 EUR -0.47% Market Closed
Market Cap: €167.8m
Write Note Create Alert Ask AI

Dividends

Akebia Therapeutics Inc
does not pay dividends

Shareholder Yield

Shareholder Yield
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Akebia Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Akebia Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

AX9 Price
Akebia Therapeutics Inc

1Y 3Y 5Y 10Y 15Y 20Y
Annual Price Range
0.8004
52w Low
0.714
52w High
2.75
Price Metrics
Average Annual Return 12.69%
Standard Deviation of Annual Returns 90.91%
Max Drawdown -93%
Shares Statistics
Market Capitalization 257.2m EUR
Shares Outstanding 209 596 000
Percentage of Shares Shorted
N/A

AX9 Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about AX9's stock splits.

Continue AX9 Research

Summary
AX9 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AX9 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AX9 stock valuation using valuation multiples.
Wall St Estimates
AX9 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AX9 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Akebia Therapeutics Inc listings:
NASDAQ • USD
AKBA
 SWB • EUR
AX9
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join 357,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.